Dave A. Miller, Ph.D.
About Dave A. Miller, Ph.D.
Dave A. Miller, Ph.D., is the Chief Scientific Officer at AustinPx, Pharmaceutics and Manufacturing, where he has worked since 2021. He holds a Ph.D. in Pharmaceutics and has over two decades of experience in pharmaceutical development, specializing in formulation technologies.
Current Role at AustinPx
Dave A. Miller, Ph.D., serves as the Chief Scientific Officer at AustinPx, Pharmaceutics and Manufacturing. He has held this position since 2021, contributing to the company's focus on pharmaceutical development in Georgetown, Texas. In this role, he leverages his extensive experience in formulation and processing technologies to enhance oral bioavailability of insoluble small molecules.
Previous Experience in the Pharmaceutical Industry
Prior to his current position, Miller worked at several notable organizations. He was a Senior Principal Scientist at Hoffmann-La Roche and served as Vice President of Research and Development at DisperSol Technologies. He also gained experience as a Process Engineer at Celanese and as a Graduate Research Assistant at the University of Texas at Austin. His early career included a two-month internship at Evonik Degussa GmbH in 2005.
Education and Expertise
Miller holds a Ph.D. in Pharmaceutics from the University of Texas at Austin, where he studied from 2003 to 2007. He also earned a Bachelor of Science in Chemical Engineering from the same institution, completing his degree in 2002. His academic background provides a strong foundation for his expertise in pharmaceutical development, particularly in formulation technologies.
Research Contributions and Publications
Dave A. Miller has made significant contributions to the field of pharmaceutical sciences. He has authored eight book chapters and published over 40 research articles in peer-reviewed journals. His work includes co-editing the First, Second, and Third Editions of the textbook, Formulating Poorly Water-Soluble Drugs, which addresses critical challenges in drug formulation.
Patents and Innovations
Miller is a co-inventor on numerous granted and pending patents worldwide, reflecting his innovative contributions to pharmaceutical technologies. Notably, he co-invented the pharmaceutical applications of KinetiSol technology, which is recognized for its advancements in drug formulation processes.